PharmiWeb.com - Global Pharma News & Resources
01-Feb-2019

My Gene Counsel Launches Cardiovascular Content for February's Heart Awareness Month

My Gene Counsel Launches Cardiovascular Content for February's Heart Awareness Month The Digital Genetic Counseling Company Expands its Coverage to Hereditary Cardiovascular Content

PR Newswire

NEW HAVEN, Conn., Feb. 1, 2019

NEW HAVEN, Conn., Feb. 1, 2019 /PRNewswire-PRWeb/ -- My Gene Counsel ("mGC"), a digital resource for genetic information, announced today that the company has extended its content reporting to include hereditary cardiovascular genes. The expansion comes just two months after the initial launch of their hereditary cancer product and is another step towards My Gene Counsel becoming the most complete, publicly available resource for hereditary diseases as the demand for personalized genetic information grows. The company provides personalized, easy-to-understand, continuously updated, web-based genetic counseling reports via Living Lab ReportsĀ®.

Because heart disease is the number one cause of death worldwide, impacting approximately 25% of the population, genetic testing for cardiovascular conditions is a growing field. Heart conditions can run in families. If deemed hereditary, individuals do have options for personalized medical care that can save their lives.

My Gene Counsel's personalized Living Lab Reports for hereditary cancer and cardiovascular genes include all genes present on standard panels from the major laboratories, as well as genes included on the American College of Medical Genetics and Genomics list of returnable findings. If someone tests positive in this category of genes, the result is considered actionable and steps can be taken to prevent or reduce disease risk.

Depending on the condition and gene involved, actions may include the use or avoidance of certain medications, interventions such as the implanting of a defibrillator, exercise reduction, avoidance of alcohol, or adoption of other healthy behaviors. Cardiogenetic conditions covered by My Gene Counsel include: familial hypercholesterolemia, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmias, aortopathies, and arrhythmogenic right ventricular cardiomyopathy (ARVS).

My Gene Counsel is the only genetics resource used in the market today that is designed for digital and mobile access. Reports are available at all hours of every day, delivering comprehensive genetics content created by experts and patient advocates. Unlike other information resources, My Gene Counsel's Living Lab Reports are continually updated with the latest information, including reclassification of gene variants, updated clinical information, clinical trial opportunities, and legislative changes. As new data unfolds, patients are alerted via email and/or text.

About My Gene Counsel:
My Gene Counsel is a HIPAA-compliant digital resource for genetic information and a one-stop-shop to stay on top of advancements tied to personal genetic test results. The company was founded in 2014 by certified genetic counselors with more than 30 years of clinical experience and leadership in genetic counseling and testing. From deep in the trenches of clinical care, they saw the need to provide consumers and clinicians with a progressive, digital method of staying up-to-date on their genetic test results. For more information, visit http://www.mygenecounsel.com.

 

SOURCE My Gene Counsel

Editor Details

Last Updated: 01-Feb-2019